AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $23,462,000 | +48.9% | 25,985,000 | +33.3% | 12.71% | -2.7% |
| Q2 2020 | $15,758,000 | +21.7% | 19,500,000 | +18.2% | 13.06% | -29.5% |
| Q1 2020 | $12,949,000 | +16.1% | 16,500,000 | +22.2% | 18.53% | +33.9% |
| Q4 2019 | $11,158,000 | -0.7% | 13,500,000 | 0.0% | 13.83% | +65.7% |
| Q3 2019 | $11,239,000 | +3.1% | 13,500,000 | 0.0% | 8.35% | +0.6% |
| Q2 2019 | $10,897,000 | – | 13,500,000 | – | 8.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mohican Financial Management, LLC | 1,500,000 | $1,492,000 | 2.87% |
| Telemetry Investments, L.L.C. | 8,000,000 | $7,780,000 | 2.78% |
| Context Capital Management, LLC | 3,500,000 | $3,405,000 | 2.28% |
| Kamunting Street Capital Management, L.P. | 2,500,000 | $2,431,000 | 1.54% |
| BASSO CAPITAL MANAGEMENT, L.P. | 12,205,000 | $11,824,000 | 1.46% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 17,500,000 | $17,269,000 | 1.34% |
| CAMDEN ASSET MANAGEMENT L P /CA | 32,375,000 | $31,485,000 | 1.04% |
| Jabre Capital Partners S.A. | 5,500,000 | $5,328,000 | 1.04% |
| City Financial Investment Co Ltd | 12,500,000 | $12,168,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,250,000 | $15,747,000 | 0.71% |